Sreekanth Appasani

Prospective validation of 4-category classification of acute pancreatitis severity.

Objective Atlanta classification divides patients with acute pancreatitis (AP) into mild and severe disease. A 4-category severity classification has been proposed based on the presence or absence of local and systemic determinants, giving rise to mild, moderate, severe, or critical AP. The aim of this study was to validate this new 4-category system of severity classification by examining markers of severity and outcome. Methods Data from 151 consecutive patients with AP from January 2009 to December 2010 [mean age (SD), 41.1 (3.5) years; 101 men] were collected. Management was standardized. Patients were classified as mild [no necrosis or organ failure (OF)], moderate (sterile necrosis or transient OF), severe [infected necrosis (IN) or persistent OF], or critical (IN and persistent OF) AP. Data were compared between groups for severity and outcome. Results There were 21 (13.9%) patients with mild, 63 (41.7%) moderate, 59 (39.1%) severe, and 8 (5.3%) critical AP. There was a significant difference between these categories for length of hospital stay, computed tomographic severity index scores, occurrence of bloodstream infections, incidence of IN, requirements for percutaneous catheter drain, numbers of operations, and mortality. Conclusions This prospective case series clinically validated the 4-category classification of AP severity.

Dynamic nature of organ failure in severe acute pancreatitis: the impact of persistent and deteriorating organ failure

BACKGROUND AND AIMS In acute pancreatitis (AP), patients with persistent organ failure [POF, duration of organ failure (OF) ≥48 h] and transient organ failure (TOF, duration of OF <48 h) have different outcomes. We have compared the clinical course and outcome of patients with severe AP (SAP) with TOF and POF in the first week of hospitalization as well as the impact of change in the OF score in the first week on patient outcome. METHODS Consecutive patients with SAP were evaluated for OF and its dynamics during the first week of hospitalization. The modified multiple organ failure score (MOFS) was used to identify OF, grade its severity and monitor its progression. The clinical course and outcome of patients were studied. RESULTS Of 114 patients, mean age 39.2 ± 13.7 years, 37 (32.5%) patients had no OF, 34 (29.8%) had TOF and 43(37.7%) had POF. Patients with POF had the higher infected necrosis, increased requirement for percutaneous drain placement, surgery and higher mortality as compared with those with TOF. The odds ratio for mortality with persistent and deteriorating OF was 26.2 [confidence interval (CI) 5.1-134.9] compared with only persistent OF. CONCLUSION The dynamics of OF in the first week of SAP predicts the clinical course and outcome. Persistent and deteriorating OF indicates a poor outcome.

Pancreatic fluid collections: What is the ideal imaging technique?

Pancreatic fluid collections (PFCs) are seen in up to 50% of cases of acute pancreatitis. The Revised Atlanta classification categorized these collections on the basis of duration of disease and contents, whether liquid alone or a mixture of fluid and necrotic debris. Management of these different types of collections differs because of the variable quantity of debris; while patients with pseudocysts can be drained by straight-forward stent placement, walled-off necrosis requires multi-disciplinary approach. Differentiating these collections on the basis of clinical severity alone is not reliable, so imaging is primarily performed. Contrast-enhanced computed tomography is the commonly used modality for the diagnosis and assessment of proportion of solid contents in PFCs; however with certain limitations such as use of iodinated contrast material especially in renal failure patients and radiation exposure. Magnetic resonance imaging (MRI) performs better than computed tomography (CT) in characterization of pancreatic/peripancreatic fluid collections especially for quantification of solid debris and fat necrosis (seen as fat density globules), and is an alternative in those situations where CT is contraindicated. Also magnetic resonance cholangiopancreatography is highly sensitive for detecting pancreatic duct disruption and choledocholithiasis. Endoscopic ultrasound is an evolving technique with higher reproducibility for fluid-to-debris component estimation with the added advantage of being a single stage procedure for both diagnosis (solid debris delineation) and management (drainage of collection) in the same sitting. Recently role of diffusion weighted MRI and positron emission tomography/CT with (18)F-FDG labeled autologous leukocytes is also emerging for detection of infection noninvasively. Comparative studies between these imaging modalities are still limited. However we look forward to a time when this gap in literature will be fulfilled.

Stents for benign and malignant esophageal strictures.

This paper presents commentaries on endotherapy for esophageal perforation/leaks; treatment of esophageal perforation; whether esophageal stents should be used for treating benign esophageal strictures; what determines the optimal stenting period in benign esophageal strictures/leaks; how to choose an esophageal stent; how a new fistula secondary to an esophageal stent should be treated; which strategy should be adopted when a fistula of a cervical anastomosis occurs; intralesional steroids for refractory esophageal strictures; balloon and bougie dilators for esophageal strictures and predictors of response to dilation; whether refractory strictures from different etiologies respond differently to endotherapy; surgical therapy of benign esophageal strictures; and whether stenoses following severe esophageal burns should be treated by esophageal resection or esophageal bypass.

Sa1351 Neutrophil Gelatinase-Associated Lipocalin: An Early Biomarker for Predicting Acute Kidney Injury in Patients With Acute Pancreatitis

GTL alone. CONCLUSIONS: High concentrations of UFA, IL-1beta and IL-8 in necrosis fluid relative to NIC fluids supports these to be the potential culprits in necrotic cell death as evidenced by high DNA content in the post-necrotic fluid. The ability of orlistat to reduce serum lipase, NEFA, UFA, LA concentrations in rat serum demonstrates its efficacy as a lipase inhibitor in this model. The high mortality, necrosis, IL-1beta and IL-8 concentrations, distant organ injury in GTL infused rats, and reduction of these with orlistat supports lipolytic generation of UFAs to be the driver of inflammation and necrosis. Therefore, the combined data suggests that lipotoxicity may drive inflammation and necrosis in human acute pancreatitis. Table 1: Human Data

Mo1340 Does the Site of Fluid Collection Alter the Clinical Course of Acute Pancreatitis? -A Prospective Observational Study

G A A b st ra ct s clear. Methods: Consecutive patients with symptomatic WOPN seen over last 7 months were prospectively included in the study. All the patients underwent EUS, MRI and abdominal ultrasoundwithin two days. On each of these investigations an attemptwas made to determine the site, size and the nature of contents of the WOPN. The echogenic material seen in the collection on EUS and abdominal ultrasound was considered as necrotic debris. On MRI, the hypo intense areas inside the collection on T2 weighted images were taken as solid debris. The solid debris was quantified by two independent observers for all three imaging modalities and the mean was taken as final value. Results: A total of 21 patients were included. There were 16 males (78.9%) and the mean age was 43.5 ± 11.13 years. The etiology was alcohol in 13 and gall stones in 6 patients. The imaging (EUS, MRI and abdominal ultrasound) was done at a mean of 12 ± 13.93 weeks of onset of abdominal pain. On EUS, 8 patients had a solid content of ≤10%, 11 had a content of 10-40% and 2 patients had a solid content of >40%. On MRI, 10 patients were noted to have a solid content of ≤10%, 9 patients had a solid content >10-40% and 2 had content of >40%. On abdominal ultrasound 9 patients had a content of ≤10% while nine patients had a solid content between 10-40%. WON could not be visualized on abdominal ultrasound in 3 patients, two of whom had a high content of solid debris on EUS/MRI. All patients in whom the collections were not visualized on abdominal ultrasound had presented within 6 weeks of onset of disease. All patients with disease duration of >6 weeks had WOPN well visualized on abdominal ultrasound. Conclusion: Trans abdominal ultrasound can help in diagnosis as well as characterization of majority of WOPN collections with comparable accuracy as that of EUS/MRI. However, collections early in the course of disease and with high content of solid debris may be difficult to evaluate on abdominal ultrasound.

Mo1342 Natural History of GI Fistulae in Acute Pancreatitis-A Prospective & Retrospective Analysis

G A A b st ra ct s clear. Methods: Consecutive patients with symptomatic WOPN seen over last 7 months were prospectively included in the study. All the patients underwent EUS, MRI and abdominal ultrasoundwithin two days. On each of these investigations an attemptwas made to determine the site, size and the nature of contents of the WOPN. The echogenic material seen in the collection on EUS and abdominal ultrasound was considered as necrotic debris. On MRI, the hypo intense areas inside the collection on T2 weighted images were taken as solid debris. The solid debris was quantified by two independent observers for all three imaging modalities and the mean was taken as final value. Results: A total of 21 patients were included. There were 16 males (78.9%) and the mean age was 43.5 ± 11.13 years. The etiology was alcohol in 13 and gall stones in 6 patients. The imaging (EUS, MRI and abdominal ultrasound) was done at a mean of 12 ± 13.93 weeks of onset of abdominal pain. On EUS, 8 patients had a solid content of ≤10%, 11 had a content of 10-40% and 2 patients had a solid content of >40%. On MRI, 10 patients were noted to have a solid content of ≤10%, 9 patients had a solid content >10-40% and 2 had content of >40%. On abdominal ultrasound 9 patients had a content of ≤10% while nine patients had a solid content between 10-40%. WON could not be visualized on abdominal ultrasound in 3 patients, two of whom had a high content of solid debris on EUS/MRI. All patients in whom the collections were not visualized on abdominal ultrasound had presented within 6 weeks of onset of disease. All patients with disease duration of >6 weeks had WOPN well visualized on abdominal ultrasound. Conclusion: Trans abdominal ultrasound can help in diagnosis as well as characterization of majority of WOPN collections with comparable accuracy as that of EUS/MRI. However, collections early in the course of disease and with high content of solid debris may be difficult to evaluate on abdominal ultrasound.

Mo1334 Validation and Comparison of the New Severity Classification Systems With Old Atlanta Classification for Severity of Acute Pancreatitis

Background Two new classification systems for the severity of acute pancreatitis (AP) have been proposed recently, the determinant based classification (DBC) and revised Atlanta classification (RAC). We aimed to validate and compare these classification systems with original Atlanta classification (OAC). Aims To validate and compare the DBC and RAC with original Atlanta classification (OAC) Methods 469 adult patients with AP admitted to a tertiary care center from January 2009-June 2013 were included in the study. The new classification systems were validated and compared in terms of outcomes (need for interventions, total hospital and intensive care unit (ICU) stay and mortality). Results The mean age of patients was 39.9±13.4 years (331 males) with the commonest etiology being alcohol (161, 34.3%) followed by gall stones (125, 26.6%). There were 119 (25.4%) patients with mild and 250 (74.6%) patients with severe AP as per OAC. Pancreatic necrosis was present in 66.1% and infected pancreatic necrosis in 23.1% patients. 126 (26.9%) patients underwent interventions (endoscopic n= 49, 10.4%, radiological n=95, 20.2% and surgical n=47, 10%). 93 (19.8%) patients died. As per DBC, 97(20.7%), 172 (36.7%), 152 (32.4%), and 48(10.2%) patients were determined to have mild, moderate, severe, and critical AP, respectively. As per RAC, 119 (25.4%), 160 (34.1%), and 190 patients (40.3%) were determined to have mild, moderately severe, and severe AP, respectively. Higher grades of severity were associated with worse outcomes in DBC, RAC and OAC. Predictive accuracies were evaluated using area under the receiver operator characteristics curve (AUROC) and Somers D co-efficient. The DBC, RAC and OAC were comparable in predicting the need for interventions (AUROC 0.53, 0.55, 0.54, p=0.36) and length of hospital stay (Somers D, 0.27, 0.26, 0.23, p=0.41). However, both DBC and RAC had comparable but better accuracy than OAC in predicting need for ICU admission (AUROC 0.73 for both vs. 0.62 for OAC, P<0.001), length of ICU stay (Somers D, 0.35 for both vs. 0.24 for OAC, p<0.001) and mortality (AUROC 0.78 for both vs. 0.61 for OAC, p<0.001). Conclusion Determinant based classification and revised Atlanta classification categorize patients into subgroups that reflect clinical outcomes. Both have comparable and higher predictive accuracy than old Atlanta classification for need for ICU admission, length of ICU stay and mortality.

Double gastric dieulafoy's lesion treated with endoscopic band ligation

Dieulafoys lesion is an uncommon cause of non-variceal upper gastrointestinal (GI) bleed. They are commonly seen in stomach and are usually single. Rarely, multiple DLs may cause clinically significant GI bleed. We report a rare case of upper GI bleed due to two DL along the lesser curvature of the stomach. Hemostasis was achieved by endoscopic band ligation. Patient did not have further recurrences and was asymptomatic after 2 years.

Su1296 Co-Existence of Pancreatic and Liver Disease in Alcoholics: A Prospective and Retrospective Analysis

and comorbidities, in patients with liver cirrhosis, CDI was independently associated with an increased LOS (adjusted mean difference, 5.2 days, 95% CI, 4.6 5.8), higher all-cause in-hospital mortality (OR 1.4, 95% CI, 1.3 1.5), and higher DTCF (3.9, 95% CI, 3.7 4.0), all p,0.0001. Conclusions: CDI is a major complication in liver cirrhosis patients, and is independently associated with poor outcomes, including increased LOS, in-hospital mortality and DTCF.